nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts from the ASENT 2007 Annual Meeting March 5–8, 2007
|
VanDenburgh, Amanda M. |
|
2007 |
4 |
4 |
p. 725-731 |
artikel |
2 |
Antigen-specific therapy of multiple sclerosis: The long-sought magic bullet
|
Steinman, Lawrence |
|
2007 |
4 |
4 |
p. 661-665 |
artikel |
3 |
Antigen-Specific Therapy of Multiple Sclerosis: The Long-Sought Magic Bullet
|
Steinman, Lawrence |
|
2007 |
4 |
4 |
p. 661-665 5 p. |
artikel |
4 |
Antigen-Specific Therapy of Multiple Sclerosis: The Long-Sought Magic Bullet
|
Steinman, Lawrence |
|
|
4 |
4 |
p. 661-665 |
artikel |
5 |
A rose by any other name? the potential consequences of microglial heterogeneity during CNS health and disease
|
Carson, Monica J. |
|
2007 |
4 |
4 |
p. 571-579 |
artikel |
6 |
A Rose by Any Other Name? The Potential Consequences of Microglial Heterogeneity During CNS Health and Disease
|
Carson, Monica J. |
|
2007 |
4 |
4 |
p. 571-579 9 p. |
artikel |
7 |
A Rose by Any Other Name? The Potential Consequences of Microglial Heterogeneity During CNS Health and Disease
|
Carson, Monica J. |
|
|
4 |
4 |
p. 571-579 |
artikel |
8 |
Author Index
|
|
|
2007 |
4 |
4 |
p. 732-733 2 p. |
artikel |
9 |
Author Index
|
|
|
|
4 |
4 |
p. 732-733 |
artikel |
10 |
Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce?
|
Savarin-Vuaillat, Carine |
|
2007 |
4 |
4 |
p. 590-601 |
artikel |
11 |
Chemokines and Chemokine Receptors in Neurological Disease: Raise, Retain, or Reduce?
|
Savarin-Vuaillat, Carine |
|
2007 |
4 |
4 |
p. 590-601 12 p. |
artikel |
12 |
Chemokines and Chemokine Receptors in Neurological Disease: Raise, Retain, or Reduce?
|
Savarin-Vuaillat, Carine |
|
|
4 |
4 |
p. 590-601 |
artikel |
13 |
Contents
|
|
|
2007 |
4 |
4 |
p. A2-A3 nvt p. |
artikel |
14 |
Contents
|
|
|
|
4 |
4 |
p. A2-A3 |
artikel |
15 |
Corticosteroids for multiple sclerosis: I. Application for treating exacerbations
|
Frohman, Elliot M. |
|
2007 |
4 |
4 |
p. 618-626 |
artikel |
16 |
Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations
|
Frohman, Elliot M. |
|
2007 |
4 |
4 |
p. 618-626 9 p. |
artikel |
17 |
Corticosteroids for Multiple Sclerosis: I. Application for Treating Exacerbations
|
Frohman, Elliot M. |
|
|
4 |
4 |
p. 618-626 |
artikel |
18 |
Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects
|
Shah, Anjali |
|
2007 |
4 |
4 |
p. 627-632 |
artikel |
19 |
Corticosteroids for Multiple Sclerosis: II. Application for Disease-Modifying Effects
|
Shah, Anjali |
|
2007 |
4 |
4 |
p. 627-632 6 p. |
artikel |
20 |
Corticosteroids for Multiple Sclerosis: II. Application for Disease-Modifying Effects
|
Shah, Anjali |
|
|
4 |
4 |
p. 627-632 |
artikel |
21 |
Editorial Board
|
|
|
2007 |
4 |
4 |
p. A1- 1 p. |
artikel |
22 |
Editorial Board
|
|
|
|
4 |
4 |
p. A1 |
artikel |
23 |
Emerging therapies for multiple sclerosis
|
Muraro, Paolo A. |
|
2007 |
4 |
4 |
p. 676-692 |
artikel |
24 |
Emerging Therapies for Multiple Sclerosis
|
Muraro, Paolo A. |
|
2007 |
4 |
4 |
p. 676-692 17 p. |
artikel |
25 |
Emerging Therapies for Multiple Sclerosis
|
Muraro, Paolo A. |
|
|
4 |
4 |
p. 676-692 |
artikel |
26 |
Immunology of neurological gene therapy: How T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses
|
Lowenstein, Pedro R. |
|
2007 |
4 |
4 |
p. 715-724 |
artikel |
27 |
Immunology of Neurological Gene Therapy: How T Cells Modulate Viral Vector-Mediated Therapeutic Transgene Expression Through Immunological Synapses
|
Lowenstein, Pedro R. |
|
2007 |
4 |
4 |
p. 715-724 10 p. |
artikel |
28 |
Immunology of Neurological Gene Therapy: How T Cells Modulate Viral Vector-Mediated Therapeutic Transgene Expression Through Immunological Synapses
|
Lowenstein, Pedro R. |
|
|
4 |
4 |
p. 715-724 |
artikel |
29 |
Immunosuppressive agents in multiple sclerosis
|
Neuhaus, Oliver |
|
2007 |
4 |
4 |
p. 654-660 |
artikel |
30 |
Immunosuppressive Agents in Multiple Sclerosis
|
Neuhaus, Oliver |
|
2007 |
4 |
4 |
p. 654-660 7 p. |
artikel |
31 |
Immunosuppressive Agents in Multiple Sclerosis
|
Neuhaus, Oliver |
|
|
4 |
4 |
p. 654-660 |
artikel |
32 |
Interferon-β treatment for multiple sclerosis
|
Bermel, Robert A. |
|
2007 |
4 |
4 |
p. 633-646 |
artikel |
33 |
Interferon-β Treatment for Multiple Sclerosis
|
Bermel, Robert A. |
|
2007 |
4 |
4 |
p. 633-646 14 p. |
artikel |
34 |
Interferon-β Treatment for Multiple Sclerosis
|
Bermel, Robert A. |
|
|
4 |
4 |
p. 633-646 |
artikel |
35 |
Mechanism of action of glatiramer acetate in treatment of multiple sclerosis
|
Weber, Martin S. |
|
2007 |
4 |
4 |
p. 647-653 |
artikel |
36 |
Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
|
Weber, Martin S. |
|
2007 |
4 |
4 |
p. 647-653 7 p. |
artikel |
37 |
Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
|
Weber, Martin S. |
|
|
4 |
4 |
p. 647-653 |
artikel |
38 |
Modulating co-stimulation
|
Viglietta, Vissia |
|
2007 |
4 |
4 |
p. 666-675 |
artikel |
39 |
Modulating Co-Stimulation
|
Viglietta, Vissia |
|
2007 |
4 |
4 |
p. 666-675 10 p. |
artikel |
40 |
Modulating Co-Stimulation
|
Viglietta, Vissia |
|
|
4 |
4 |
p. 666-675 |
artikel |
41 |
MRI in multiple sclerosis: What’s inside the toolbox?
|
Neema, Mohit |
|
2007 |
4 |
4 |
p. 602-617 |
artikel |
42 |
MRI in Multiple Sclerosis: What’s Inside the Toolbox?
|
Neema, Mohit |
|
2007 |
4 |
4 |
p. 602-617 16 p. |
artikel |
43 |
MRI in Multiple Sclerosis: What’s Inside the Toolbox?
|
Neema, Mohit |
|
|
4 |
4 |
p. 602-617 |
artikel |
44 |
Neuroimmunotherapeutics comes of age
|
Ransohoff, Richard M. |
|
2007 |
4 |
4 |
p. 569-570 |
artikel |
45 |
Neuroimmunotherapeutics Comes of Age
|
Ransohoff, Richard M. |
|
2007 |
4 |
4 |
p. 569-570 2 p. |
artikel |
46 |
Neuroimmunotherapeutics Comes of Age
|
Ransohoff, Richard M. |
|
|
4 |
4 |
p. 569-570 |
artikel |
47 |
Poster Abstract #2: A Cluster Analysis of Treatment Response in Acute Bipolar Mania
|
Lipkovich, Ilya |
|
2007 |
4 |
4 |
p. 725- 1 p. |
artikel |
48 |
Poster Abstract #2: A Cluster Analysis of Treatment Response in Acute Bipolar Mania
|
Lipkovich, Ilya |
|
|
4 |
4 |
p. 725 |
artikel |
49 |
Poster Abstract #6: Age-Related Motor Impairment in Mice Lacking Vg1037, an Orphan GPCR Localized to Brain Motor Systems
|
Torres, Richard |
|
2007 |
4 |
4 |
p. 726-727 2 p. |
artikel |
50 |
Poster Abstract #6: Age-Related Motor Impairment in Mice Lacking Vg1037, an Orphan GPCR Localized to Brain Motor Systems
|
Torres, Richard |
|
|
4 |
4 |
p. 726-727 |
artikel |
51 |
Poster Abstract #7: Anticonvulsant Effects of a Synthetic Progestin, Norethindrone, But Not Its A-Ring Reduced Metabolite in Mice
|
Kaminski, Rafal M. |
|
2007 |
4 |
4 |
p. 727- 1 p. |
artikel |
52 |
Poster Abstract #7: Anticonvulsant Effects of a Synthetic Progestin, Norethindrone, But Not Its A-Ring Reduced Metabolite in Mice
|
Kaminski, Rafal M. |
|
|
4 |
4 |
p. 727 |
artikel |
53 |
Poster Abstract #11: A Research Network for the Experimental Therapeutics of Rare Neurologic Disorders
|
Herr, Barbara E. |
|
2007 |
4 |
4 |
p. 728- 1 p. |
artikel |
54 |
Poster Abstract #11: A Research Network for the Experimental Therapeutics of Rare Neurologic Disorders
|
Herr, Barbara E. |
|
|
4 |
4 |
p. 728 |
artikel |
55 |
Poster Abstract #16: Building Patient Trust in Clinical Research: The Parkinson’s Disease Experience
|
Elliott, Robin |
|
2007 |
4 |
4 |
p. 730- 1 p. |
artikel |
56 |
Poster Abstract #16: Building Patient Trust in Clinical Research: The Parkinson’s Disease Experience
|
Elliott, Robin |
|
|
4 |
4 |
p. 730 |
artikel |
57 |
Poster Abstract #3: Cognitive Status of Patients With Schizophrenia as Modulator or Mediator of Functional Outcome
|
Lipkovich, Ilya |
|
2007 |
4 |
4 |
p. 725-726 2 p. |
artikel |
58 |
Poster Abstract #3: Cognitive Status of Patients With Schizophrenia as Modulator or Mediator of Functional Outcome
|
Lipkovich, Ilya |
|
|
4 |
4 |
p. 725-726 |
artikel |
59 |
Poster Abstract #12: Continuous Subcutaneous Apomorphine as an Aid in Regaining Consciousness After a Severe Traumatic Brain Injury
|
Fridman, Esteban |
|
2007 |
4 |
4 |
p. 728-729 2 p. |
artikel |
60 |
Poster Abstract #12: Continuous Subcutaneous Apomorphine as an Aid in Regaining Consciousness After a Severe Traumatic Brain Injury
|
Fridman, Esteban |
|
|
4 |
4 |
p. 728-729 |
artikel |
61 |
Poster Abstract #17: Double-Blind Randomized Treatment of Poststroke Depression With Nefiracetam
|
Robinson, Robert G. |
|
2007 |
4 |
4 |
p. 730- 1 p. |
artikel |
62 |
Poster Abstract #17: Double-Blind Randomized Treatment of Poststroke Depression With Nefiracetam
|
Robinson, Robert G. |
|
|
4 |
4 |
p. 730 |
artikel |
63 |
Poster Abstract #9: Implementing Data Standards: Challenges from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Common Data Elements Project
|
Kunitz, Selma C. |
|
2007 |
4 |
4 |
p. 727-728 2 p. |
artikel |
64 |
Poster Abstract #9: Implementing Data Standards: Challenges from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Common Data Elements Project
|
Kunitz, Selma C. |
|
|
4 |
4 |
p. 727-728 |
artikel |
65 |
Poster Abstract #4: Metabotropic Glutamate Receptor 5 Modulates Microglial Activity and Provides Neuroprotection
|
Byrnes, Kimberly R. |
|
2007 |
4 |
4 |
p. 726- 1 p. |
artikel |
66 |
Poster Abstract #4: Metabotropic Glutamate Receptor 5 Modulates Microglial Activity and Provides Neuroprotection
|
Byrnes, Kimberly R. |
|
|
4 |
4 |
p. 726 |
artikel |
67 |
Poster Abstract #5: NAIP-based Neuroprotection Drug Screening
|
Tanaka, Kazunori |
|
2007 |
4 |
4 |
p. 726- 1 p. |
artikel |
68 |
Poster Abstract #5: NAIP-based Neuroprotection Drug Screening
|
Tanaka, Kazunori |
|
|
4 |
4 |
p. 726 |
artikel |
69 |
Poster Abstract #18: National Institutes of Health Rapid Access to Interventional Development (NIH-RAID) Pilot Program
|
Badman, D. |
|
2007 |
4 |
4 |
p. 731- 1 p. |
artikel |
70 |
Poster Abstract #18: National Institutes of Health Rapid Access to Interventional Development (NIH-RAID) Pilot Program
|
Badman, D. |
|
|
4 |
4 |
p. 731 |
artikel |
71 |
Poster Abstract #8: PARP Inhibitors Attenuate Secondary Neuronal Cell Death and Improve Neurological Dysfunction After Traumatic Brain Injury
|
Stoica, Bogdan A. |
|
2007 |
4 |
4 |
p. 727- 1 p. |
artikel |
72 |
Poster Abstract #8: PARP Inhibitors Attenuate Secondary Neuronal Cell Death and Improve Neurological Dysfunction After Traumatic Brain Injury
|
Stoica, Bogdan A. |
|
|
4 |
4 |
p. 727 |
artikel |
73 |
Poster Abstract #1: Passive and Active Functional Tasks Are the Main Reasons for Treatment of Upper Limb Spasticity in Post-Stroke Patients Among Neurologists, Physiatrists, and Primary Care Physicians
|
VanDenburgh, Amanda M. |
|
2007 |
4 |
4 |
p. 725- 1 p. |
artikel |
74 |
Poster Abstract #1: Passive and Active Functional Tasks Are the Main Reasons for Treatment of Upper Limb Spasticity in Post-Stroke Patients Among Neurologists, Physiatrists, and Primary Care Physicians
|
VanDenburgh, Amanda M. |
|
|
4 |
4 |
p. 725 |
artikel |
75 |
Poster Abstract #13: Possible Role of Primidone in the Treatment of Restless Leg Syndrome (RLS)
|
Mettu, Krishna |
|
2007 |
4 |
4 |
p. 729- 1 p. |
artikel |
76 |
Poster Abstract #13: Possible Role of Primidone in the Treatment of Restless Leg Syndrome (RLS)
|
Mettu, Krishna |
|
|
4 |
4 |
p. 729 |
artikel |
77 |
Poster Abstract #10: Preliminary Experience With Functional MRI (fMRI) Detects Altered Neural Networks Subserving Executive Function and Attention in Subjects With Partial Ornithine Transcarbamylase Deficiency (OTC)
|
Gropman, Andrea |
|
2007 |
4 |
4 |
p. 728- 1 p. |
artikel |
78 |
Poster Abstract #10: Preliminary Experience With Functional MRI (fMRI) Detects Altered Neural Networks Subserving Executive Function and Attention in Subjects With Partial Ornithine Transcarbamylase Deficiency (OTC)
|
Gropman, Andrea |
|
|
4 |
4 |
p. 728 |
artikel |
79 |
Poster Abstract #15: Preliminary Experience With MRS at 3T in Urea Cycle Disorders Detects Altered Metabolism in Partial Ornithine Transcarbamylase Deficiency
|
Gropman, Andrea |
|
2007 |
4 |
4 |
p. 730- 1 p. |
artikel |
80 |
Poster Abstract #15: Preliminary Experience With MRS at 3T in Urea Cycle Disorders Detects Altered Metabolism in Partial Ornithine Transcarbamylase Deficiency
|
Gropman, Andrea |
|
|
4 |
4 |
p. 730 |
artikel |
81 |
Poster Abstract #14: Recruiting Older Diverse Populations into Studies of Parkinson’s Disease: A Mixed Methods Approach to Development of an Intervention
|
Tilley, Barbara C. |
|
2007 |
4 |
4 |
p. 729-730 2 p. |
artikel |
82 |
Poster Abstract #14: Recruiting Older Diverse Populations into Studies of Parkinson’s Disease: A Mixed Methods Approach to Development of an Intervention
|
Tilley, Barbara C. |
|
|
4 |
4 |
p. 729-730 |
artikel |
83 |
Prospects for neural stem cell-based therapies for neurological diseases
|
Imitola, Jaime |
|
2007 |
4 |
4 |
p. 701-714 |
artikel |
84 |
Prospects for Neural Stem Cell-Based Therapies for Neurological Diseases
|
Imitola, Jaime |
|
2007 |
4 |
4 |
p. 701-714 14 p. |
artikel |
85 |
Prospects for Neural Stem Cell-Based Therapies for Neurological Diseases
|
Imitola, Jaime |
|
|
4 |
4 |
p. 701-714 |
artikel |
86 |
Statins—Treatment option for central nervous system autoimmune disease?
|
Weber, Martin S. |
|
2007 |
4 |
4 |
p. 693-700 |
artikel |
87 |
Statins—Treatment Option for Central Nervous System Autoimmune Disease?
|
Weber, Martin S. |
|
2007 |
4 |
4 |
p. 693-700 8 p. |
artikel |
88 |
Statins—Treatment Option for Central Nervous System Autoimmune Disease?
|
Weber, Martin S. |
|
|
4 |
4 |
p. 693-700 |
artikel |
89 |
Subject Index
|
|
|
2007 |
4 |
4 |
p. 734-737 4 p. |
artikel |
90 |
Subject Index
|
|
|
|
4 |
4 |
p. 734-737 |
artikel |
91 |
Targeting MMPs in acute and chronic neurological conditions
|
Yong, V. Wee |
|
2007 |
4 |
4 |
p. 580-589 |
artikel |
92 |
Targeting MMPs in Acute and Chronic Neurological Conditions
|
Yong, V. Wee |
|
2007 |
4 |
4 |
p. 580-589 10 p. |
artikel |
93 |
Targeting MMPs in Acute and Chronic Neurological Conditions
|
Yong, V. Wee |
|
|
4 |
4 |
p. 580-589 |
artikel |